Despite that, a recent study shows how the administration of hemin in early AP increases HO-1 expression, reducing pancreatic damage and TNF-α levels, and increasing the release of anti-inflammatory IL-10 by macrophages, stellate cells and T helper type 2 cells [111]. The gene discussed is HMOX1; the disease is alkaline phosphatase measurement.